|
Market Closed -
OTC Markets
17:57:44 26/05/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0630 USD | -29.84% |
|
-9.99% | -30.00% |
| Market Cap | 1.34M 1.16M 1.09M 990K 1.86M 128M 1.87M 13.05M 5.02M 64.96M 5.02M 4.91M 207M | P/E 2023 |
885x | P/E 2024 | 25x |
|---|---|---|---|---|---|
| Enterprise Value | 405K 350K 331K 300K 563K 38.8M 567K 3.95M 1.52M 19.68M 1.52M 1.49M 62.75M | EV / Sales 2023 |
0.22x | EV / Sales 2024 | 1.65x |
| Free-Float |
98.9% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -29.84% | ||
| 1 week | -9.99% | ||
| Current month | -19.23% | ||
| 1 month | +28.57% | ||
| 3 months | -26.40% | ||
| 6 months | -29.21% | ||
| Current year | -30.00% |
| 1 week | 0.06 | 0.07 | |
| 1 month | 0.05 | 0.08 | |
| Current year | 0.03 | 0.16 | |
| 1 year | 0.03 | 0.16 | |
| 3 years | 0.02 | 0.16 | |
| 5 years | 0.02 | 0.51 | |
| 10 years | 0.02 | 0.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
W. Ulmer
CEO | Chief Executive Officer | - | 15/09/2019 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 15/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
W. Ulmer
CHM | Chairman | - | 23/09/2020 |
Cathy Richmond
BRD | Director/Board Member | - | 15/09/2019 |
Irwin Gruverman
BRD | Director/Board Member | 91 | 23/09/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -29.84% | -9.99% | +5.00% | -2.63% | 1.56M | ||
| -0.19% | +1.09% | +51.85% | +97.36% | 1,015B | ||
| +0.33% | -0.71% | +50.62% | +65.50% | 642B | ||
| +0.49% | +5.73% | +20.88% | +72.92% | 463B | ||
| -0.22% | +1.98% | +36.33% | +38.93% | 353B | ||
| -0.07% | -9.26% | +15.16% | +24.78% | 265B | ||
| -0.31% | +0.61% | +2.73% | +12.04% | 254B | ||
| -1.53% | -4.46% | +36.90% | +44.08% | 206B | ||
| -1.60% | -7.71% | -20.79% | -59.60% | 191B | ||
| +0.49% | -0.23% | +30.00% | +93.34% | 182B | ||
| Average | -3.22% | -3.02% | +22.87% | +38.67% | 357.02B | |
| Weighted average by Cap. | -0.09% | -2.21% | +33.99% | +59.53% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 793K 687K 649K 588K 1.1M 76.03M 1.11M 7.75M 2.98M 38.55M 2.98M 2.91M 123M | 811K 703K 665K 602K 1.13M 77.82M 1.14M 7.93M 3.05M 39.46M 3.05M 2.98M 126M |
| Net income | 1.55K 1.35K 1.27K 1.15K 2.16K 149K 2.18K 15.18K 5.84K 75.54K 5.83K 5.7K 241K | 107K 92.43K 87.4K 79.13K 149K 10.24M 150K 1.04M 401K 5.19M 401K 392K 16.55M |
| Net Debt | -1.13M -978K -924K -837K -1.57M -108M -1.58M -11.03M -4.24M -54.9M -4.24M -4.15M -175M | -931K -806K -763K -690K -1.3M -89.31M -1.31M -9.1M -3.5M -45.29M -3.5M -3.42M -144M |
Employees
16
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | $0.0700 | +7.51% | 57,890 |
| 10/09/26 | $0.0651 | -7.00% | 2,000 |
- Stock Market
- Stocks
- IVRO Stock
Select your edition
All financial news and data tailored to specific country editions
















